IL297155A - Aptamers for use in the treatment of Corona - Google Patents

Aptamers for use in the treatment of Corona

Info

Publication number
IL297155A
IL297155A IL297155A IL29715522A IL297155A IL 297155 A IL297155 A IL 297155A IL 297155 A IL297155 A IL 297155A IL 29715522 A IL29715522 A IL 29715522A IL 297155 A IL297155 A IL 297155A
Authority
IL
Israel
Prior art keywords
aptamer
seq
sars
virus
infection
Prior art date
Application number
IL297155A
Other languages
English (en)
Hebrew (he)
Original Assignee
Berlin Cures GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2021/059328 external-priority patent/WO2021205012A1/en
Application filed by Berlin Cures GmbH filed Critical Berlin Cures GmbH
Publication of IL297155A publication Critical patent/IL297155A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL297155A 2020-04-09 2021-10-14 Aptamers for use in the treatment of Corona IL297155A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20168929 2020-04-09
EP20176023 2020-05-22
EP20180781 2020-06-18
EP20204036 2020-10-27
PCT/EP2021/059328 WO2021205012A1 (en) 2020-04-09 2021-04-09 Aptamers for use in the treatment of coronaviridae infections

Publications (1)

Publication Number Publication Date
IL297155A true IL297155A (en) 2022-12-01

Family

ID=84191962

Family Applications (1)

Application Number Title Priority Date Filing Date
IL297155A IL297155A (en) 2020-04-09 2021-10-14 Aptamers for use in the treatment of Corona

Country Status (11)

Country Link
US (1) US12606828B2 (enExample)
EP (1) EP4133083A1 (enExample)
JP (1) JP2023521361A (enExample)
KR (1) KR20220166337A (enExample)
CN (1) CN115768895A (enExample)
AU (1) AU2021252151A1 (enExample)
BR (1) BR112022020439A2 (enExample)
CA (1) CA3175067A1 (enExample)
IL (1) IL297155A (enExample)
MX (1) MX2022012618A (enExample)
ZA (1) ZA202212179B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3007984T3 (en) * 2021-04-09 2025-03-21 Berlin Cures GmbH Aptamers for use in the treatment of coronaviridae infections
KR102937192B1 (ko) * 2023-01-25 2026-03-17 주식회사 리젠시스랩 사스 코로나 바이러스 2 특이적 압타머 및 이의 용도
WO2025146959A1 (ko) * 2024-01-02 2025-07-10 충북대학교 산학협력단 SARSCoV2의 외피 단백질에 특이적으로 결합하는 DNA 앱타머 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009508473A (ja) * 2005-08-26 2009-03-05 アーケミツクス・コーポレイシヨン 高親和性でトロンビンに結合するアプタマー
EP2497828A1 (en) * 2011-03-07 2012-09-12 Charité - Universitätsmedizin Berlin Use of aptamers in therapy and/or diagnosis of autoimmune diseases
KR102596343B1 (ko) * 2016-11-23 2023-10-31 베를린 큐어스 게엠베하 TLR9 활성화의 저해 및/또는 억제에 사용되는 압타머(aptamer)

Also Published As

Publication number Publication date
US12606828B2 (en) 2026-04-21
BR112022020439A2 (pt) 2022-11-29
JP2023521361A (ja) 2023-05-24
AU2021252151A1 (en) 2022-12-08
CA3175067A1 (en) 2021-10-14
MX2022012618A (es) 2022-11-07
CN115768895A (zh) 2023-03-07
ZA202212179B (en) 2025-03-26
KR20220166337A (ko) 2022-12-16
EP4133083A1 (en) 2023-02-15
US20230140490A1 (en) 2023-05-04

Similar Documents

Publication Publication Date Title
CA3013683C (en) Oligonucleotides for reduction of pd-l1 expression
US12606828B2 (en) Aptamers for use in the treatment of Coronaviridae infections
JP6587934B2 (ja) Pdgfおよびvegf結合アプタマー、および、pdgfおよびvegfが介在する病気の治療へのそれらの使用
US10266830B2 (en) Use of aptamers in therapy and/or diagnosis of autoimmune diseases
JP2021035369A (ja) 自己抗体関連疾患に対する使用のためのアプタマー
WO2021205012A1 (en) Aptamers for use in the treatment of coronaviridae infections
JP2026021387A (ja) コロナウイルス科感染の治療において使用するためのアプタマー
HK40104624B (en) Aptamers for use in the treatment of coronaviridae infections
HK40104624A (en) Aptamers for use in the treatment of coronaviridae infections
CN117642179A (zh) 流感病毒核酸脂质颗粒疫苗
CN121419780A (zh) 用于抑制甲型流感病毒基因表达的RNAi试剂、其组合物和使用方法
NZ785335A (en) Oligonucleotides for reduction of pd-l1 expression
HK1230650A1 (en) Use of aptamers in therapy and/or diagnosis of autoimmune diseases